Albumin-Fused FIX: Longer Hemophilia B Treatment
Here’s a breakdown of the details provided in the text:
Research Publication:
* Title: Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties
* Journal: nature communications
* DOI: 10.1038/s41467-025-62955-9
* Article Link: https://www.nature.com/articles/s41467-025-62955-9
* Publication Year: 2025
Source of Information:
* Provided by: University of oslo
* University Website: http://www.uio.no/english/
News/Article Information:
* Topic: Engineered albumin-fused FIX extends hemophilia B treatment half-life beyond standard 3-4 day window
* date: September 29, 2025
* Citation: Engineered albumin-fused FIX extends hemophilia B treatment half-life beyond standard 3-4 day window (2025, September 29) (for print purposes)
